Approved uses of Docefrez include the treatment of certain types of breast cancer, prostate cancer, and non-small cell lung cancer. It is approved only for adults, as it has not been adequately studied in children. There are also some unapproved, or off-label, uses for this medication, such as treating bladder cancer, ovarian cancer, and certain forms of skin cancer.
What Is Docefrez Used For?Docefrez™ (docetaxel) is a prescription chemotherapy medication that belongs to a group of medicines known as taxanes. It is given as a slow injection into a vein (an intravenous, or IV, infusion). Docefrez is approved to treat the following types of cancer:
Using Docefrez for Breast CancerBreast cancer is cancer that starts in the tissue of the breast. It is one of the most common types of cancer in women, and one of the leading causes of cancer-related deaths in women.
Breast cancer can be invasive or non-invasive. Invasive breast cancer is cancer that has moved into the surrounding breast tissue. Non-invasive breast cancer is cancer that remains in the ducts or lobes of the breast.
Invasive breast cancer that is large, has spread to lymph nodes in the armpit or other areas around the breast, or has spread to tissue around the breast (such as the chest wall or skin) is considered locally advanced breast cancer. Cancer that has spread to other areas of the body is called metastatic breast cancer (see Breast Cancer Stages for more information).
Docefrez is approved to treat locally advanced or metastatic breast cancer. It is reserved for use after at least one other chemotherapy treatment has been tried but failed.